Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

Rhonda Bentley-Lewis, David Aguilar, Matthew C Riddle, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Hertzel C Gerstein, Peter Johnston, Lars V Køber, Francesca Lawson, Eldrin F Lewis, Aldo P Maggioni, John J V McMurray, Lin Ping, Jeffrey L Probstfield, Scott D Solomon, Jean-Claude Tardif, Yujun Wu, Marc A Pfeffer, ELIXA Investigators

74 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo'. Together they form a unique fingerprint.

Medicine & Life Sciences